- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Adia Nutrition Inc.: Adia Nutrition, Inc. Drops Explosive Sneak Peek of Upcoming Documentary Featuring TNA Wrestling Star Jeff Sciullo (Elias) | 312 | Newsfile | Winter Park, Florida--(Newsfile Corp. - June 2, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA) is thrilled to announce that the powerful new documentary showcasing TNA Wrestling star and former WWE... ► Artikel lesen | |
| ADIA NUTRITION Aktie jetzt für 0€ handeln | |||||
| 26.05. | Adia Nutrition Inc.: Adia Nutrition Announces Expanded Stem Cell Coverage Through Independent Monthly-Membership Health Care Sharing Ministry | 207 | Newsfile | Winter Park, Florida--(Newsfile Corp. - May 26, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company advancing regenerative medicine and innovative healthcare solutions, today announced... ► Artikel lesen | |
| 15.05. | Adia Nutrition Inc.: ADIA Nutrition, Inc. Reports Strong Revenue Growth and Operational Momentum for First Quarter 2026 | 263 | Newsfile | Winter Park, Florida--(Newsfile Corp. - May 15, 2026) - ADIA Nutrition, Inc. (OTCQB: ADIA), a leader in advanced nutrition and regenerative health solutions, today announced its 3rd party reviewed... ► Artikel lesen | |
| 15.05. | Adia Nutrition, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 11.05. | ADIA Nutrition erhält IRB-Zulassung für vier klinische Studien | 3 | Investing.com Deutsch | ||
| 11.05. | ADIA Nutrition receives IRB approval for four clinical studies | 1 | Investing.com | ||
| 11.05. | Adia Nutrition Inc.: ADIA Nutrition Announces IRB Approval of All Four Clinical Studies and Registration of Kidney Health Study on ClinicalTrials.gov | 329 | Newsfile | Winter Park, Florida--(Newsfile Corp. - May 11, 2026) - ADIA Nutrition, Inc. (OTCQB: ADIA), a publicly traded company advancing regenerative medicine through its subsidiary Adia Med of Winter Park... ► Artikel lesen | |
| 05.05. | Adia Nutrition Inc.: Adia Nutrition Announces IRB Approval and ClinicalTrials.gov Submission for Groundbreaking Stem Cell Study in Chronic Kidney Disease (CKD) | 511 | Newsfile | Winter Park, Florida--(Newsfile Corp. - May 5, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA), a publicly traded company based in Winter Park, Florida, dedicated to advancing regenerative therapies... ► Artikel lesen | |
| 28.04. | Adia Nutrition Inc.: Adia Nutrition Announces Three Pivotal Clinical Studies Receive Major IRB Milestone - Final Approval Now Clearly in Sight | 294 | Newsfile | Winter Park, Florida--(Newsfile Corp. - April 28, 2026) - Adia Nutrition, (OTCQB: ADIA) a leader in advanced regenerative health solutions, today announced a major milestone in its clinical research... ► Artikel lesen | |
| 22.04. | Adia Nutrition seeks larger property for Florida clinic expansion | 3 | Investing.com | ||
| 22.04. | Adia Nutrition sucht größere Immobilie für Expansion der Klinik in Florida | 2 | Investing.com Deutsch | ||
| 22.04. | Adia Nutrition Inc.: Adia Nutrition, Inc. Looking to Acquire Larger Property to Expand Flagship Clinic in Winter Park, Reports Strong Operational Momentum in Q1 2026 and Provides Optimistic Outlook for Remainder of the Year | 129 | Newsfile | Winter Park, Florida--(Newsfile Corp. - April 22, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA), a leader in regenerative medicine, stem cell therapies, and biologic products through its Adia Med clinics... ► Artikel lesen | |
| 15.04. | Adia Nutrition announces corporate name change to Adia Med | 2 | Seeking Alpha | ||
| 15.04. | Adia Nutrition Inc.: Adia Nutrition, Inc. Announces Corporate Name Change to Adia Med, Inc. to Better Align with Its Regenerative Medicine and Biologics Business Model | 331 | Newsfile | Winter Park, Florida--(Newsfile Corp. - April 15, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA), a publicly traded company focused on regenerative medicine, stem cell therapies, and biologic products... ► Artikel lesen | |
| 08.04. | Adia Nutrition Inc.: Adia Nutrition Strikes Major Partnership with Leading Atlanta Clinic to Launch Groundbreaking Autism Clinical Study | 313 | Newsfile | Winter Park, Florida--(Newsfile Corp. - April 8, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA), a leader in regenerative medicine, today announced a strategic partnership with a prominent clinic in... ► Artikel lesen | |
| 02.04. | Adia Nutrition, Inc. GAAP EPS of $0.00 | 1 | Seeking Alpha | ||
| 01.04. | Adia Nutrition Inc.: Adia Nutrition, Inc. Reports Strong Revenue Growth in 2025 Annual Report, Highlighting Transition to Regenerative Medicine and Full SEC Reporting Status | 369 | Newsfile | Winter Park, Florida--(Newsfile Corp. - April 1, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA), a leader in regenerative medicine, stem cell therapies, and premium wellness solutions, today announced... ► Artikel lesen | |
| 31.03. | Adia Nutrition, Inc. - 10-K, Annual Report | - | SEC Filings | ||
| 24.03. | Adia Nutrition Inc.: Tonight: Adia Nutrition and UCF CARD Host Live Zoom on Revolutionary Stem Cell Study for Autism - Strong Interest Already Building | 217 | Newsfile | Winter Park, Florida--(Newsfile Corp. - March 24, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine through its Adia Med division, is excited to announce a special virtual... ► Artikel lesen | |
| 17.03. | Adia Nutrition Inc.: Adia Med of Winter Park Appoints Amy Dalrymple, APRN, Former Mrs. Florida United States, to Lead Regenerative Aesthetics Division | 522 | Newsfile | Winter Park, Florida--(Newsfile Corp. - March 17, 2026) - Adia Nutrition Inc. (OTCQB: ADIA) is proud to announce that its subsidiary, Adia Med of Winter Park, has appointed Amy Dalrymple, MSN, APRN... ► Artikel lesen |
1 2 3 4 Weiter >>
70 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 57,38 | -0,03 % | BrightSpring stockholders price 15M share offering at $58.75 | ||
| FRESENIUS | 36,670 | +1,97 % | Während Merck, Amgen, Novo Nordisk und Fresenius Milliarden bewegen, wächst die Fantasie im Zelltherapie-Sektor | ||
| VERU | 4,220 | -0,24 % | Veru stock holds at Outperform as Oppenheimer cites Novo deal | ||
| SIEMENS HEALTHINEERS | 34,650 | +3,43 % | Mentice AB: Mentice and Siemens Healthineers Announce Co-Marketing Partnership to Advance Neurovascular Treatment Planning | Gothenburg, Sweden - June 2026 - Mentice AB, a global leader in simulation and clinical decision support solutions for Image-Guided Therapies, today announced a co-marketing agreement with Siemens Healthineers... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,740 | +4,78 % | UBS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Sell' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat FMC mit einem Kursziel von 37 Euro auf "Sell" belassen. Anstehende Daten eines Konkurrenzprodukts könnten das Potenzial für optimistischere... ► Artikel lesen | |
| BILLIONTOONE | 104,49 | -0,10 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 15,065 | -0,03 % | Alignment Healthcare Named to the Fortune 1000 2026 List for Second Consecutive Year | ||
| GENEDX | 56,25 | -0,04 % | Sema4.ai's autonomous agent building platform gets simpler to use, adds deeper business context and more | ||
| HEARTFLOW | 28,790 | -0,07 % | Heartflow, Inc.: Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the... ► Artikel lesen | |
| PROGYNY | 25,470 | -0,04 % | Progyny, Inc.: New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System | ||
| CARL ZEISS MEDITEC | 26,640 | +1,52 % | Aktien - Shortseller-Positionen: Carl Zeiss Meditec, Evotec, HelloFresh, Kontron, LPKF Laser, TeamViewer | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| ANTERIS TECHNOLOGIES GLOBAL | 9,660 | +0,10 % | ANTERIS TECHNOLOGIES GLOBAL CORP.: Notification of cessation of securities - AVR | ||
| CLEARPOINT NEURO | 14,320 | 0,00 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint | Announcement is made after successful proof-of-concept trial in a preclinical model of intravenous delivery of large molecule tracers across the blood-brain barrier guided by prototype systems, including... ► Artikel lesen | |
| UNITEDHEALTH | 341,60 | 0,00 % | Aktien New York Ausblick: Techwerte unter Druck nach KI-Ausblick von Broadcom | NEW YORK (dpa-AFX) - Ein enttäuschender Ausblick des Chipkonzerns Broadcom dürfte am Donnerstag für Moll-Stimmung an der Technologiebörse Nasdaq sorgen. Der Broker IG taxierte den viel beachteten Branchenindex... ► Artikel lesen | |
| BUTTERFLY NETWORK | 5,200 | +0,29 % | Butterfly Network adds former B. Braun CEO to board |
Das Unternehmen ADIA NUTRITION INC kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ADIA NUTRITION INC finden Sie auf Wallstreet Online.